IDO1 and neoplasm: To achieve spatiotemporal control of tumor aggregation and deep penetration of nanoparticles, Feng et al.77 also developed light-induced nanoparticles (LINCs) to control tissue penetration and drug release of these carriers by NIR, while inducing ICD and IDO-1 inhibition to improve tumor immunotherapy78.